Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (7.2.2019), 1-10, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Lee, Eun Byul
Kim, Jung-Hee
Hur, Wonhee
Choi, Jung Eun
Kim, Sung Min
Park, Dong Jun
Kang, Byung-Yoon
Lee, Gil Won
Yoon, Seung Kew
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-38533-7
- URN
-
urn:nbn:de:101:1-2019043019574333571395
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Eun Byul
- Kim, Jung-Hee
- Hur, Wonhee
- Choi, Jung Eun
- Kim, Sung Min
- Park, Dong Jun
- Kang, Byung-Yoon
- Lee, Gil Won
- Yoon, Seung Kew
- SpringerLink (Online service)
Ähnliche Objekte (12)
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität